OTCPK:AFGV.Y

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems, and IT solutions worldwide. More Details

Rewards

Trading at 87.2% below our estimate of its fair value

Risk Analysis

No risks detected for AFGV.Y from our risk checks.


Snowflake Analysis

Excellent balance sheet and fair value.


Similar Companies

Share Price & News

How has Agfa-Gevaert's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: AFGV.Y has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

0%

AFGV.Y

2.4%

US Healthcare Services

0.08%

US Market


1 Year Return

n/a

AFGV.Y

54.7%

US Healthcare Services

12.8%

US Market

Return vs Industry: Insufficient data to determine how AFGV.Y performed against the US Healthcare Services industry.

Return vs Market: Insufficient data to determine how AFGV.Y performed against the US Market.


Shareholder returns

AFGV.YIndustryMarket
7 Day0%2.4%0.08%
30 Day0%-2.4%-1.8%
90 Dayn/a10.2%7.2%
1 Yearn/a55.1%54.7%15.3%12.8%
3 Yearn/a103.1%101.8%39.2%29.9%
5 Yearn/a153.3%151.0%88.3%67.1%

Price Volatility Vs. Market

How volatile is Agfa-Gevaert's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Agfa-Gevaert undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: AFGV.Y ($8.53) is trading below our estimate of fair value ($66.77)

Significantly Below Fair Value: AFGV.Y is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: AFGV.Y is unprofitable, so we can't compare its PE Ratio to the US Healthcare Services industry average.

PE vs Market: AFGV.Y is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate AFGV.Y's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: AFGV.Y is good value based on its PB Ratio (0.8x) compared to the US Healthcare Services industry average (5.1x).


Next Steps

Future Growth

How is Agfa-Gevaert forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

142.8%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: AFGV.Y is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: AFGV.Y is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: AFGV.Y is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: AFGV.Y's revenue is expected to decline over the next 3 years (-2.6% per year).

High Growth Revenue: AFGV.Y's revenue is forecast to decline over the next 3 years (-2.6% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if AFGV.Y's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Agfa-Gevaert performed over the past 5 years?

-63.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: AFGV.Y is currently unprofitable.

Growing Profit Margin: AFGV.Y is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: AFGV.Y is unprofitable, and losses have increased over the past 5 years at a rate of 63.1% per year.

Accelerating Growth: Unable to compare AFGV.Y's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AFGV.Y is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-4.8%).


Return on Equity

High ROE: AFGV.Y has a negative Return on Equity (-12.79%), as it is currently unprofitable.


Next Steps

Financial Health

How is Agfa-Gevaert's financial position?


Financial Position Analysis

Short Term Liabilities: AFGV.Y's short term assets (€1.8B) exceed its short term liabilities (€629.0M).

Long Term Liabilities: AFGV.Y's short term assets (€1.8B) exceed its long term liabilities (€1.1B).


Debt to Equity History and Analysis

Debt Level: AFGV.Y's debt to equity ratio (1.8%) is considered satisfactory.

Reducing Debt: AFGV.Y's debt to equity ratio has reduced from 127.7% to 1.8% over the past 5 years.

Debt Coverage: AFGV.Y's debt is well covered by operating cash flow (821.4%).

Interest Coverage: AFGV.Y is unprofitable, therefore interest payments are not well covered by earnings.


Balance Sheet


Next Steps

Dividend

What is Agfa-Gevaert current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate AFGV.Y's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate AFGV.Y's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if AFGV.Y's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AFGV.Y's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of AFGV.Y's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

7.2yrs

Average management tenure


CEO

Pascal Juery (55 yo)

0.58

Tenure

Mr. Pascal Juéry serves as Chief Executive Officer at Agfa-Gevaert NV since February 1, 2020 and also serves as its President since 2020. Mr. Juéry serves as a Director of Agfa-Gevaert NV since 2020 and al ...


Leadership Team

NamePositionTenureCompensationOwnership
Pascal Juery
President0.58yrno datano data
Dirk De Man
Chief Financial Officer2.33yrsno datano data
Wilfried Van Lishout
Compliance Officer & Company Secretaryno datano datano data
Viviane Dictus
Director of Corporate Communications12yrsno datano data
- Boyer
Executive Vice Presidentno datano datano data
Luc Delagaye
President of Offset Solutions12.33yrsno datano data
Luc Thijs
President of Agfa Healthcareno datano datano data

7.2yrs

Average Tenure

55.5yo

Average Age

Experienced Management: AFGV.Y's management team is seasoned and experienced (7.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Pascal Juery
President0.58yrno datano data
Christian Reinaudo
Director10.67yrs€1.69mno data
Hilde Laga
Independent Director5.33yrs€70.00kno data
Helen Routh
Independent Director1.33yrs€62.50kno data
Klaus Röhrig
Non-Executive Director1.83yrs€180.00kno data
M.R.C. Pensaert
Independent Director2.33yrs€77.50kno data
Frank Aranzana
Independent Chairman of the Board0.67yr€60.00kno data

1.8yrs

Average Tenure

58yo

Average Age

Experienced Board: AFGV.Y's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Agfa-Gevaert NV's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Agfa-Gevaert NV
  • Ticker: AFGV.Y
  • Exchange: OTCPK
  • Founded: 1867
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: €599.711m
  • Listing Market Cap: €711.485m
  • Shares outstanding: 167.75m
  • Website: https://www.agfa.com

Number of Employees


Location

  • Agfa-Gevaert NV
  • Septestraat 27
  • Mortsel
  • Antwerp
  • 2640
  • Belgium

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
AFGV.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDJun 1999
AGFBENXTBR (Euronext Brussels)YesOrdinary SharesBEEURJun 1999
AGEDB (Deutsche Boerse AG)YesOrdinary SharesDEEURJun 1999
0MFULSE (London Stock Exchange)YesOrdinary SharesGBEURJun 1999
AGFBBBATS-CHIXE (BATS 'Chi-X Europe')YesOrdinary SharesGBEURJun 1999
AGFBSWX (SIX Swiss Exchange)YesOrdinary SharesCHCHFJun 1999
AFGV.YOTCPK (Pink Sheets LLC)ADRUSUSDOct 2008

Biography

Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems, and IT solutions worldwide. The company’s Offset Solutions segment provides commercial, newspaper, and packag ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/20 05:54
End of Day Share Price2020/07/29 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.